Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NOV-002
DRUG
3 trials
Sponsors
Cellectar Biosciences, Inc.
, M.D. Anderson Cancer Center
Conditions
Leukemia
Myelodysplastic Syndrome
Non Small Cell Lung Cancer
Ovarian Cancer
Phase 2
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
Completed
NCT00345540
Cellectar Biosciences, Inc.
Ovarian Cancer
Start: 2006-07-31
End: 2008-06-30
Updated: 2015-03-10
NOV-002 in Myelodysplastic Syndrome (MDS)
Withdrawn
NCT00960726
M.D. Anderson Cancer Center
Leukemia, Myelodysplastic Syndrome
Updated: 2012-07-30
Phase 3
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Completed
NCT00347412
Cellectar Biosciences, Inc.
Non Small Cell Lung Cancer
Start: 2006-11-30
End: 2010-02-28
Updated: 2022-07-25